Resistance Signatures Manifested in Early Drug Response in Cancer and Across Species
Preprint
Abstract
Therapeutic resistance is a major cause of cancer treatment failure, with increasing evidence suggesting a non-genetic basis. This non-genetic resistance is often due to drug-resistant transcriptional cell states, either induced by treatment or pre-existing in some cells. However, the connection between early cellular drug response and long-term resistance is poorly understood. Moreover, it is unknown whether resistance-associated early transcriptional responses are evolutionarily conserved. Integrating long-term drug resistance and early drug response data across multiple cancer cell lines, bacteria, and yeast, our findings indicate that cancer states in drug-naive populations and shortly after treatment share transcriptional properties with fully resistant populations, some of which are evolutionarily conserved. CRISPR-Cas9 knockout of resistant states' markers increased sensitivity to Prexasertib in ovarian cancer cells. Finally, early resistant state signatures discriminated therapy responders from non-responders across multiple human cancer trials, and distinguished premalignant breast lesions that progress to malignancy from those that do not.Keywords
Funding Information
- National Cancer Institute (1-ZIA-BC011979-02)
- National Institutes of Health (1-ZIA-BC010830-17)
This publication has 68 references indexed in Scilit:
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent MechanismsMolecular Cancer Therapeutics, 2015
- MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screensGenome Biology, 2014
- Drug Resistance in Cancer: An OverviewCancers, 2014
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Nonheritable Cellular Variability Accelerates the Evolutionary Processes of CancerPLOS Biology, 2012
- Robust rank aggregation for gene list integration and meta-analysisBioinformatics, 2012
- MYC as a regulator of ribosome biogenesis and protein synthesisNature Reviews Cancer, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasionBritish Journal of Cancer, 2010